Dr. Wafa QuliKhan serves as Associate Director of Clinical Operations at Kivu Bioscience. She brings more than eight years of experience across clinical operations and research and development, spanning academic, site, and industry settings. Her work has supported programs that integrate scientific rigor with high-quality patient care across global clinical environments.

Dr. QuliKhan has led and managed all phases of clinical trials in multiple therapeutic areas, including oncology, dermatology, rheumatology, neurology, and rare diseases. She has overseen complex, multi-regional studies across the United States, Canada, Europe, China, and Pakistan, ensuring full compliance with Good Clinical Practice (GCP) guidelines and global pharmacovigilance standards. Throughout her career, she has partnered with cross-functional teams in clinical development, operations, data management, regulatory, and quality, contributing to efficient study execution in diverse and highly regulated settings.

Before joining Kivu Bioscience, Dr. QuliKhan held clinical research and operational roles at the University of Texas Health, LabCorp Drug Development, and ICON, where she supported a wide range of early- and late-stage clinical programs.

Dr. QuliKhan earned her M.B.B.S. from Xi’an Jiaotong University, College of Medicine.